-
2
-
-
0042345004
-
-
Health and economic impact of the premenstrual syndrome
-
Borenstein JE, Dean BB, Endicott J et al. Health and economic impact of the premenstrual syndrome. J. Report. Med. 48(7), 515-524 (2003).
-
(2003)
J. Report. Med
, vol.48
, Issue.7
, pp. 515-524
-
-
Borenstein, J.E.1
Dean, B.B.2
Endicott, J.3
-
3
-
-
0038406087
-
Recurrence of symptoms of premenstrual dysphoric disorder after the cessation of luteal-phase fluoxetine treatment
-
Pearlstein T, Joliat MJ, Brown EB, Miner CM. Recurrence of symptoms of premenstrual dysphoric disorder after the cessation of luteal-phase fluoxetine treatment. Am. J. Obstet. Gynecol. 188, 887-895 (2003).
-
(2003)
Am. J. Obstet. Gynecol
, vol.188
, pp. 887-895
-
-
Pearlstein, T.1
Joliat, M.J.2
Brown, E.B.3
Miner, C.M.4
-
4
-
-
0036271001
-
Severity of premenstrual symptoms in a health maintenance organization population
-
Sternfeld B, Swindle R, Chawla A, Long S. Severity of premenstrual symptoms in a health maintenance organization population. Obstet. Gynecol. 99(6), 1014-1024 (2002).
-
(2002)
Obstet. Gynecol
, vol.99
, Issue.6
, pp. 1014-1024
-
-
Sternfeld, B.1
Swindle, R.2
Chawla, A.3
Long, S.4
-
5
-
-
0024788859
-
Depressive episodes in premenstrual syndrome
-
Mortola JF, Girton L, Yen SS. Depressive episodes in premenstrual syndrome. Am. J. Obstet. Gynecol. 161(6, Pt 1), 1682-1687 (1989).
-
(1989)
Am. J. Obstet. Gynecol
, vol.161
, Issue.6 and PART 1
, pp. 1682-1687
-
-
Mortola, J.F.1
Girton, L.2
Yen, S.S.3
-
6
-
-
0005946141
-
Premenstrual syndrome
-
American College of Obstetricians and Gynecologists
-
American College of Obstetricians and Gynecologists. Premenstrual syndrome. ACOG Pract. Bull. 15, 1-9 (2000).
-
(2000)
ACOG Pract. Bull
, vol.15
, pp. 1-9
-
-
-
7
-
-
0011855501
-
Premenstrual syndrome
-
Ransom SB Ed, WB Saunders Company, PA, USA
-
Ginsburg KA, Dinsay R. Premenstrual syndrome. In: Practical Strategies in Obstetrics and Gynecology. Ransom SB (Ed.). WB Saunders Company, PA, USA, 684-694 (2000).
-
(2000)
Practical Strategies in Obstetrics and Gynecology
, pp. 684-694
-
-
Ginsburg, K.A.1
Dinsay, R.2
-
9
-
-
0242482637
-
The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS/ PMDD)
-
Halbreich U, Borenstein J, Pearlstein T, Kahn LS. The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS/ PMDD). Psychoneuroendocrinology Suppl. 3, 1-23 (2003).
-
(2003)
Psychoneuroendocrinology Suppl
, vol.3
, pp. 1-23
-
-
Halbreich, U.1
Borenstein, J.2
Pearlstein, T.3
Kahn, L.S.4
-
10
-
-
10644285993
-
-
World Health Organization, World Health Organization, Geneva, Switzerland
-
World Health Organization. The ICD-10 Classification of Mental, Behavioral and Development Disorders, 10th Revision, World Health Organization, Geneva, Switzerland (1987).
-
(1987)
The ICD-10 Classification of Mental, Behavioral and Development Disorders, 10th Revision
-
-
-
11
-
-
33645383081
-
Premenstrual syndrome in adolescents: Diagnosis and treatment
-
Rapkin AJ, Mikacich JA. Premenstrual syndrome in adolescents: diagnosis and treatment. Pediatr. Endocrinol. Rev. 3(Suppl. 1), 132-137 (2006),
-
(2006)
Pediatr. Endocrinol. Rev
, vol.3
, Issue.SUPPL. 1
, pp. 132-137
-
-
Rapkin, A.J.1
Mikacich, J.A.2
-
12
-
-
0642311952
-
Premenstrual syndrome and premenstrual dysphoric disorder: Definitions and diagnosis
-
Freeman EW. Premenstrual syndrome and premenstrual dysphoric disorder: definitions and diagnosis. Psychoneuroendocrinology 28(Suppl. 3), 25-37 (2003).
-
(2003)
Psychoneuroendocrinology
, vol.28
, Issue.SUPPL. 3
, pp. 25-37
-
-
Freeman, E.W.1
-
13
-
-
0038246106
-
The etiology, biology, and evolving pathology of premenstrual syndromes
-
Halbreich U. The etiology, biology, and evolving pathology of premenstrual syndromes. Psychoneuroendocrinology 28(Suppl. 3), 55-99 (2003).
-
(2003)
Psychoneuroendocrinology
, vol.28
, Issue.SUPPL. 3
, pp. 55-99
-
-
Halbreich, U.1
-
14
-
-
0023483493
-
Genetic and environmental variation in menstrual cycle: Histories of two British twin samples
-
Van der Akker OBA et al. Genetic and environmental variation in menstrual cycle: histories of two British twin samples. Acta Genet. Med. Gemellol. (Roma) 36, 541-548 (1987).
-
(1987)
Acta Genet. Med. Gemellol. (Roma)
, vol.36
, pp. 541-548
-
-
Van der Akker, O.B.A.1
-
15
-
-
0026576953
-
Genetic and environmental factors in the aetiology of menstrual, premenstrual and neurotic symptoms: A population-based twin study
-
Kendler KS et al. Genetic and environmental factors in the aetiology of menstrual, premenstrual and neurotic symptoms: a population-based twin study. Psychol. Med. 22, 85-100 (1992).
-
(1992)
Psychol. Med
, vol.22
, pp. 85-100
-
-
Kendler, K.S.1
-
16
-
-
0025776112
-
The relationship between perimenstrual depressive mood and depressive illness
-
Warner P. The relationship between perimenstrual depressive mood and depressive illness. J. Affect. Disord. 23, 9-23 (1991).
-
(1991)
J. Affect. Disord
, vol.23
, pp. 9-23
-
-
Warner, P.1
-
17
-
-
0027514990
-
The menstrual cycle and mood disorders
-
Endicott J: The menstrual cycle and mood disorders. J. Affect. Disord. 29(2-3), 193-200 (1993).
-
(1993)
J. Affect. Disord
, vol.29
, Issue.2-3
, pp. 193-200
-
-
Endicott, J.1
-
18
-
-
0023193169
-
Whole-blood serotonin in premenstrual syndrome
-
Rapkin AJ, Edelmuth E, Chang LC et al. Whole-blood serotonin in premenstrual syndrome. Obstet. Gynecol. 70(4), 533-537 (1987).
-
(1987)
Obstet. Gynecol
, vol.70
, Issue.4
, pp. 533-537
-
-
Rapkin, A.J.1
Edelmuth, E.2
Chang, L.C.3
-
19
-
-
30644474376
-
Exploratory study of premenstrual symptoms and serotonin variability. Arch Womens Ment
-
Clayton AH, Keller AE, Leslie C et al. Exploratory study of premenstrual symptoms and serotonin variability. Arch Womens Ment. Health 9(1), 51-57 (2006).
-
(2006)
Health
, vol.9
, Issue.1
, pp. 51-57
-
-
Clayton, A.H.1
Keller, A.E.2
Leslie, C.3
-
20
-
-
0033971503
-
Neuroendocrine response to an intravenous L-tryptophan challenge in women with premenstrual syndrome
-
Rasgon N, Mcguire M, Tanavoli S et al. Neuroendocrine response to an intravenous L-tryptophan challenge in women with premenstrual syndrome. Fertil. Steril. 73(1), 144-149 (2000).
-
(2000)
Fertil. Steril
, vol.73
, Issue.1
, pp. 144-149
-
-
Rasgon, N.1
Mcguire, M.2
Tanavoli, S.3
-
21
-
-
0034922239
-
Neuroactive steroid-serotonergic interaction: Responses to an intravenous L-tryptophan challenge in women with premenstrual syndrome
-
14525-14533
-
Rasgon N, Serra M, Biggio G et al. Neuroactive steroid-serotonergic interaction: responses to an intravenous L-tryptophan challenge in women with premenstrual syndrome. Eur. J. Endocrinol. 14525-14533 (2001).
-
(2001)
Eur. J. Endocrinol
-
-
Rasgon, N.1
Serra, M.2
Biggio, G.3
-
22
-
-
33750966749
-
A PET study of 5-HT1A receptors at different phases of the menstrual cycle in women with premenstrual dysphoria
-
Jovanovic H, Cerin A, Karlsson P et al. A PET study of 5-HT1A receptors at different phases of the menstrual cycle in women with premenstrual dysphoria. Psychiatry Res. 148(2-3), 185-193 (2006).
-
(2006)
Psychiatry Res
, vol.148
, Issue.2-3
, pp. 185-193
-
-
Jovanovic, H.1
Cerin, A.2
Karlsson, P.3
-
23
-
-
69849083027
-
-
Wyatt KM, Dimmock PW, O'Brien PM. Selective serotonin reuptake inhibitors for premenstrual syndrome. Cochrane Database Syst. Rev. 4, CD001396 (2002).
-
Wyatt KM, Dimmock PW, O'Brien PM. Selective serotonin reuptake inhibitors for premenstrual syndrome. Cochrane Database Syst. Rev. 4, CD001396 (2002).
-
-
-
-
24
-
-
0032851143
-
Differential response to antidepressants in women with premenstrual syndrome/premenstrual dysphoric disorder: A randomized controlled trial
-
Freeman EW, Rickets K, Sondheimer SJ et al. Differential response to antidepressants in women with premenstrual syndrome/premenstrual dysphoric disorder: a randomized controlled trial. Arch. Gen. Psychiatry 56(10), 932-939 (1999).
-
(1999)
Arch. Gen. Psychiatry
, vol.56
, Issue.10
, pp. 932-939
-
-
Freeman, E.W.1
Rickets, K.2
Sondheimer, S.J.3
-
25
-
-
10744221911
-
Pathogenesis in menstrual cycle-linked disorders
-
Backstrom T, Andersson A, Andree L et al. Pathogenesis in menstrual cycle-linked disorders. Ann. NY Acad. Sci. 1007, 42-53 (2003).
-
(2003)
Ann. NY Acad. Sci
, vol.1007
, pp. 42-53
-
-
Backstrom, T.1
Andersson, A.2
Andree, L.3
-
26
-
-
0032556992
-
Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome
-
Schmidt PJ, Nieman LK, Danaceau MA et al. Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome. N. Engl. J. Med. 338(4), 256-257 (1998).
-
(1998)
N. Engl. J. Med
, vol.338
, Issue.4
, pp. 256-257
-
-
Schmidt, P.J.1
Nieman, L.K.2
Danaceau, M.A.3
-
27
-
-
0022483382
-
Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor
-
Majewska MD, Harrison NL, Schwartz RD et al. Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. Science 232(4753), 1004-1007 (1986).
-
(1986)
Science
, vol.232
, Issue.4753
, pp. 1004-1007
-
-
Majewska, M.D.1
Harrison, N.L.2
Schwartz, R.D.3
-
28
-
-
0030762277
-
Progesterone metabolite allopregnanolone in women with premenstrual syndrome
-
Rapkin Aj, Morgan M, Goldman L et al. Progesterone metabolite allopregnanolone in women with premenstrual syndrome. Obstet. Gynecol. 90(5), 709-714 (1997).
-
(1997)
Obstet. Gynecol
, vol.90
, Issue.5
, pp. 709-714
-
-
Rapkin, A.1
Morgan, M.2
Goldman, L.3
-
29
-
-
0029961691
-
Relationship between symptom severity and steroid variation in women with premenstrual syndrome: Study on serum pregnenolone, pregnenolone sulfate, 5 α-pregnane-3,20-dione and 3 α-hydroxy-5 α-pregnan-20-one
-
Wang M, Seippel L, Purdy RH, Bäckström T. Relationship between symptom severity and steroid variation in women with premenstrual syndrome: study on serum pregnenolone, pregnenolone sulfate, 5 α-pregnane-3,20-dione and 3 α-hydroxy-5 α-pregnan-20-one. J. Clin. Endocrinol. Metab. 81(3), 1076-1082 (1996).
-
(1996)
J. Clin. Endocrinol. Metab
, vol.81
, Issue.3
, pp. 1076-1082
-
-
Wang, M.1
Seippel, L.2
Purdy, R.H.3
Bäckström, T.4
-
30
-
-
0028037297
-
Circulating levels of anxiolytic steroids in the luteal phase in women with premenstrual syndrome and in control subjects
-
Schmidt PJ, Purdy RH, Moore PH Jr et al. Circulating levels of anxiolytic steroids in the luteal phase in women with premenstrual syndrome and in control subjects. J. Clin. Endocrinol. Metab. 79(5), 1256-1260 (1994).
-
(1994)
J. Clin. Endocrinol. Metab
, vol.79
, Issue.5
, pp. 1256-1260
-
-
Schmidt, P.J.1
Purdy, R.H.2
Moore Jr, P.H.3
-
31
-
-
0036231790
-
A receptor gene regulation in the brain and anxiety behavior
-
A receptor gene regulation in the brain and anxiety behavior. Steroids 67(6), 519-528 (2002).
-
(2002)
Steroids
, vol.67
, Issue.6
, pp. 519-528
-
-
Smith, S.S.1
-
32
-
-
0037298949
-
GABA receptors, progesterone and premenstrual dysphoric disorder
-
Sundström Poromaa I, Smith S, Gulinello M. GABA receptors, progesterone and premenstrual dysphoric disorder. Arch. Womens Ment. Health 6(1), 23-41 (2003).
-
(2003)
Arch. Womens Ment. Health
, vol.6
, Issue.1
, pp. 23-41
-
-
Sundström Poromaa, I.1
Smith, S.2
Gulinello, M.3
-
33
-
-
34547811620
-
Cyclical changes in calcium metabolism across the menstrual cycle in women with premenstrual dysphoric disorder
-
Thys-Jacobs S, McMahon D, Bilesikian JP. Cyclical changes in calcium metabolism across the menstrual cycle in women with premenstrual dysphoric disorder. J Clin. Endocrinol. Metab. 92(8), 2952-2959 (2007).
-
(2007)
J Clin. Endocrinol. Metab
, vol.92
, Issue.8
, pp. 2952-2959
-
-
Thys-Jacobs, S.1
McMahon, D.2
Bilesikian, J.P.3
-
34
-
-
0034734709
-
Efficacy of selective serotonin-reuptake inhibitors in premenstrual syndrome: A systematic review
-
Dimmock PW, Wyatt KM, Jones PW et al. Efficacy of selective serotonin-reuptake inhibitors in premenstrual syndrome: a systematic review. Lancet 356, 1131-1136 (2000).
-
(2000)
Lancet
, vol.356
, pp. 1131-1136
-
-
Dimmock, P.W.1
Wyatt, K.M.2
Jones, P.W.3
-
35
-
-
23844502550
-
Lueal phase dosing with paroxetine controlled release (Cr) in the treatment of premenstrual dyshoric disorder
-
Steiner M, Hirshberg AL, Bergeron R et al. Lueal phase dosing with paroxetine controlled release (Cr) in the treatment of premenstrual dyshoric disorder. Am. J Obstet. Gynecol. 193(2), 352-360 (2005).
-
(2005)
Am. J Obstet. Gynecol
, vol.193
, Issue.2
, pp. 352-360
-
-
Steiner, M.1
Hirshberg, A.L.2
Bergeron, R.3
-
36
-
-
0036709923
-
Premenstrual daily fluoxetine for premenstrual dysphoric disorder: A placebo-controlled, clinical trial using computerized diaries
-
Cohen LS, Miner C, Brown EW et al. Premenstrual daily fluoxetine for premenstrual dysphoric disorder: a placebo-controlled, clinical trial using computerized diaries. Obstet. Gynecol. 100(3), 435-444 (2002).
-
(2002)
Obstet. Gynecol
, vol.100
, Issue.3
, pp. 435-444
-
-
Cohen, L.S.1
Miner, C.2
Brown, E.W.3
-
37
-
-
0030759158
-
Intermittent luteal phase sertraline treatment of dysphoric premenstrual syndrome
-
Halbreich U, Smoller JW. Intermittent luteal phase sertraline treatment of dysphoric premenstrual syndrome. J. Clin. Psychiatry 58(9), 399-402 (1997).
-
(1997)
J. Clin. Psychiatry
, vol.58
, Issue.9
, pp. 399-402
-
-
Halbreich, U.1
Smoller, J.W.2
-
38
-
-
0034534382
-
Compliance to antidepressant drug therapy for treatment of premenstrual syndrome
-
Sundström-Poromaa I, Bixo M, Björn I et al. Compliance to antidepressant drug therapy for treatment of premenstrual syndrome. J. Psychosom. Obstet. Gynaecol. 21(4), 205-211 (2000).
-
(2000)
J. Psychosom. Obstet. Gynaecol
, vol.21
, Issue.4
, pp. 205-211
-
-
Sundström-Poromaa, I.1
Bixo, M.2
Björn, I.3
-
39
-
-
0036384236
-
Selective serotonin reuptake inhibitors for premenstrual dysphoric disorder: The emerging gold standard?
-
Pearlstein T. Selective serotonin reuptake inhibitors for premenstrual dysphoric disorder: the emerging gold standard? Drugs 62 (13), 1869-1885 (2002).
-
(2002)
Drugs
, vol.62
, Issue.13
, pp. 1869-1885
-
-
Pearlstein, T.1
-
40
-
-
0028145381
-
Long-term fluoxetine treatment of late luteal phase dysphoric disorder
-
Pearlstein TB, Stone AB. Long-term fluoxetine treatment of late luteal phase dysphoric disorder. J. Clin. Psychiatry. 55, 332-335 (1994).
-
(1994)
J. Clin. Psychiatry
, vol.55
, pp. 332-335
-
-
Pearlstein, T.B.1
Stone, A.B.2
-
41
-
-
42949168966
-
Selective serotonin reuptake inhibitors for premenstrual syndrome and premenstrual dysphoric disorder. a meta-analysis
-
Shah NR, Jones JB, Aperi J et al. Selective serotonin reuptake inhibitors for premenstrual syndrome and premenstrual dysphoric disorder. a meta-analysis. Obstet. Gynecol. 111(5), 1175-1182 (2008).
-
(2008)
Obstet. Gynecol
, vol.111
, Issue.5
, pp. 1175-1182
-
-
Shah, N.R.1
Jones, J.B.2
Aperi, J.3
-
42
-
-
0347357748
-
Impact of oral contraceptive pill use on premenstrual mood: Predictors of improvement and deterioration
-
Joffe H, Cohen LS, Harlow BL. Impact of oral contraceptive pill use on premenstrual mood: Predictors of improvement and deterioration. Am. J. Obstet. Gynecol. 189(6), 1523-1530 (2003).
-
(2003)
Am. J. Obstet. Gynecol
, vol.189
, Issue.6
, pp. 1523-1530
-
-
Joffe, H.1
Cohen, L.S.2
Harlow, B.L.3
-
43
-
-
0033168809
-
Effect of 21-day and 24-day oral contraceptive regimens containing gestodene (60 microg) and ethinyl estradiol (15 microg) on ovarian activity
-
Sullivan H, Furniss H, Spona J et al. Effect of 21-day and 24-day oral contraceptive regimens containing gestodene (60 microg) and ethinyl estradiol (15 microg) on ovarian activity. Fertil. Steril. 72(1), 115-120 (1999).
-
(1999)
Fertil. Steril
, vol.72
, Issue.1
, pp. 115-120
-
-
Sullivan, H.1
Furniss, H.2
Spona, J.3
-
45
-
-
0028910917
-
Drospirenone: A novel progestogen with antimineralcorticoid and antiandrogenic activity. Pharmacological characterization in animal models
-
Muhn P, Krattemacher R, Beier S et al. Drospirenone: a novel progestogen with antimineralcorticoid and antiandrogenic activity. Pharmacological characterization in animal models. Contraception 51(2), 99-110 (1995).
-
(1995)
Contraception
, vol.51
, Issue.2
, pp. 99-110
-
-
Muhn, P.1
Krattemacher, R.2
Beier, S.3
-
46
-
-
0033954689
-
Hormonal withdrawal symptoms in oral contraceptive users
-
Sulak PJ, Scow RD, Preece C. Hormonal withdrawal symptoms in oral contraceptive users. Obstet. Gynecol. 95(2), 261-266 (2000).
-
(2000)
Obstet. Gynecol
, vol.95
, Issue.2
, pp. 261-266
-
-
Sulak, P.J.1
Scow, R.D.2
Preece, C.3
-
47
-
-
23944510662
-
Efficacy of a new low-dose oral contraceptive with drospirenone in premenstrual dysphoric disorder
-
Yonkers KA, Brown C, Pearlstein TB et al. Efficacy of a new low-dose oral contraceptive with drospirenone in premenstrual dysphoric disorder. Obstet. Gynecol. 106(3), 492-501 (2005).
-
(2005)
Obstet. Gynecol
, vol.106
, Issue.3
, pp. 492-501
-
-
Yonkers, K.A.1
Brown, C.2
Pearlstein, T.B.3
-
48
-
-
27944495205
-
Treatment of premenstrual dysphoric disorder with a new drospirenone-containing oral contraceptive formulation
-
Pearlstein TB, Bachmann GA, Zacur HA et al. Treatment of premenstrual dysphoric disorder with a new drospirenone-containing oral contraceptive formulation. Contraception 72(6), 414-421 (2005).
-
(2005)
Contraception
, vol.72
, Issue.6
, pp. 414-421
-
-
Pearlstein, T.B.1
Bachmann, G.A.2
Zacur, H.A.3
-
49
-
-
34047154390
-
-
Westhoff CL, Heartwell S, Edwards S et al. Oral contraceptive discontinuation: do side effects matter? Am. J. Obstet. Gynecol. 196(4), 412-416; discussion 412. e6 (2007).
-
Westhoff CL, Heartwell S, Edwards S et al. Oral contraceptive discontinuation: do side effects matter? Am. J. Obstet. Gynecol. 196(4), 412-416; discussion 412. e6 (2007).
-
-
-
-
50
-
-
0025729905
-
Successful treatment of severe premenstrual syndrome by combined use of gonadotrophin-releasing hormone agonist and estrogen/progestin
-
Mortola JF, Girton L, Fischer U. Successful treatment of severe premenstrual syndrome by combined use of gonadotrophin-releasing hormone agonist and estrogen/progestin. J. Clin. Endocrinol. Metab. 71, 252A-252F (1991).
-
(1991)
J. Clin. Endocrinol. Metab
, vol.71
-
-
Mortola, J.F.1
Girton, L.2
Fischer, U.3
-
51
-
-
2942512800
-
The effectiveness of GnRHa with and without 'add-back' therapy in treating premenstrual syndrome: A meta analysis
-
Wyatt KM, Dimmock PW, Ismail KM et al. The effectiveness of GnRHa with and without 'add-back' therapy in treating premenstrual syndrome: a meta analysis. BJOG 111(6), 585-593 (2004).
-
(2004)
BJOG
, vol.111
, Issue.6
, pp. 585-593
-
-
Wyatt, K.M.1
Dimmock, P.W.2
Ismail, K.M.3
-
52
-
-
0036252249
-
Assessing the assessment measures for menstrual cycle symptoms: A guide for researchers and clinicians
-
Haywood A, Slade P, King H. Assessing the assessment measures for menstrual cycle symptoms: a guide for researchers and clinicians. J. Psychosom. Res. 52(4), 223-237 (2002).
-
(2002)
J. Psychosom. Res
, vol.52
, Issue.4
, pp. 223-237
-
-
Haywood, A.1
Slade, P.2
King, H.3
-
53
-
-
0036238328
-
Measurement properties of the calendar of premenstrual experience in patients with premenstrual syndrome
-
Feuerstein M, Shaw WS. Measurement properties of the calendar of premenstrual experience in patients with premenstrual syndrome. J. Report. Med. 47(4), 279-289 (2002).
-
(2002)
J. Report. Med
, vol.47
, Issue.4
, pp. 279-289
-
-
Feuerstein, M.1
Shaw, W.S.2
-
54
-
-
0014356696
-
The development of a menstrual distress questionnaire
-
Moos RH. The development of a menstrual distress questionnaire. Psychosom. Med. 30(6), 853-867 (1968).
-
(1968)
Psychosom. Med
, vol.30
, Issue.6
, pp. 853-867
-
-
Moos, R.H.1
-
55
-
-
30644476862
-
Daily Record of severity of problems (DRSP): Reliability and validity
-
Endicott J, Nee J, Harrison W. Daily Record of severity of problems (DRSP): reliability and validity. Arch. Womens Ment. Health 9(1), 41-49 (2006).
-
(2006)
Arch. Womens Ment. Health
, vol.9
, Issue.1
, pp. 41-49
-
-
Endicott, J.1
Nee, J.2
Harrison, W.3
-
56
-
-
34247635164
-
Using the daily record of severity of problems as a screening instrument for premenstrual syndrome
-
Borenstein JE, Dean BB, Yonkers KA, Endicott J. Using the daily record of severity of problems as a screening instrument for premenstrual syndrome. J. Obstet. Gynecol. 109(5), 1068-1075 (2007).
-
(2007)
J. Obstet. Gynecol
, vol.109
, Issue.5
, pp. 1068-1075
-
-
Borenstein, J.E.1
Dean, B.B.2
Yonkers, K.A.3
Endicott, J.4
-
57
-
-
0034671279
-
SF-36 health survey update
-
Ware JE Jr. SF-36 health survey update. Spine 25 (24), 3130-3139 (2000).
-
(2000)
Spine
, vol.25
, Issue.24
, pp. 3130-3139
-
-
Ware Jr., J.E.1
-
58
-
-
0017100059
-
Assessment of social adjustment by patient self-report
-
Weissman MM, Bothwell S. Assessment of social adjustment by patient self-report. Arch. Gen. Psychiatry 33(9), 1111-1115 (1976).
-
(1976)
Arch. Gen. Psychiatry
, vol.33
, Issue.9
, pp. 1111-1115
-
-
Weissman, M.M.1
Bothwell, S.2
-
59
-
-
41449111038
-
-
Development and validation of the Premenstrual Symptoms Impact Survey PMSIS, a disease-specific quality of life assessment tool
-
Wallenstein GV, Blaisdell-Gross B, Gajria K et al. Development and validation of the Premenstrual Symptoms Impact Survey (PMSIS): a disease-specific quality of life assessment tool. J. Womens Health (Larchmt) 17(3), 439-450 (2008).
-
(2008)
J. Womens Health (Larchmt
, vol.17
, Issue.3
, pp. 439-450
-
-
Wallenstein, G.V.1
Blaisdell-Gross, B.2
Gajria, K.3
-
60
-
-
0034999148
-
The burden of illness of cancer: Economic cost and auality of life
-
Brown ML, Lipscomb J, Snyder C. The burden of illness of cancer: economic cost and auality of life. Annu. Rev. Public Health 22, 91-113 (2001).
-
(2001)
Annu. Rev. Public Health
, vol.22
, pp. 91-113
-
-
Brown, M.L.1
Lipscomb, J.2
Snyder, C.3
-
61
-
-
0034008808
-
Psychosocial functioning in women with premenstrual dysphoric disorder before and after treatment with sertraline or placebo
-
Pearlstein TB, Halbreich U, Batzar ED et al. Psychosocial functioning in women with premenstrual dysphoric disorder before and after treatment with sertraline or placebo. J. Clin. Psychiatry 61, 101-109 (2000).
-
(2000)
J. Clin. Psychiatry
, vol.61
, pp. 101-109
-
-
Pearlstein, T.B.1
Halbreich, U.2
Batzar, E.D.3
-
62
-
-
20044396590
-
Quality-of-life impairment in depressive and anxiety disorders
-
Rappaport MH. Quality-of-life impairment in depressive and anxiety disorders. Am. J. Psychiatry 162(6), 1171-1118 (2005).
-
(2005)
Am. J. Psychiatry
, vol.162
, Issue.6
, pp. 1171-1118
-
-
Rappaport, M.H.1
-
63
-
-
54349114274
-
Frequency, intensity and impact of premenstrual syndrome in medical students
-
Nisar N, Zehra N, Haider G et al. Frequency, intensity and impact of premenstrual syndrome in medical students. J. Coll. Physicians Surg. Pak. 18(8), 481-484 (2008).
-
(2008)
J. Coll. Physicians Surg. Pak
, vol.18
, Issue.8
, pp. 481-484
-
-
Nisar, N.1
Zehra, N.2
Haider, G.3
-
64
-
-
0032750213
-
The impact of premenstrual symptomatology on functioning and treatment-seeking behavior: Experience from the United States, United Kingdom, and France
-
Hylan TR, Sundell K, Judge R. The impact of premenstrual symptomatology on functioning and treatment-seeking behavior: experience from the United States, United Kingdom, and France. J. Womens Health Gend. Based Med. 8(8), 1043-1052 (1999).
-
(1999)
J. Womens Health Gend. Based Med
, vol.8
, Issue.8
, pp. 1043-1052
-
-
Hylan, T.R.1
Sundell, K.2
Judge, R.3
-
65
-
-
0033819681
-
Premenstrual symptom severity: Impact on social functioning and treatment-seeking behaviors
-
Robinson RL, Swindle RW. Premenstrual symptom severity: impact on social functioning and treatment-seeking behaviors. J. Womens Health Gend. Based Med. 9(7), 757-768 (2000).
-
(2000)
J. Womens Health Gend. Based Med
, vol.9
, Issue.7
, pp. 757-768
-
-
Robinson, R.L.1
Swindle, R.W.2
-
66
-
-
22244472670
-
Effects of antidepressants on quality of life in women with premenstrual dysphoric disorder
-
Freeman EW. Effects of antidepressants on quality of life in women with premenstrual dysphoric disorder. Pharmacoeconomics 23(5), 433-444 (2005).
-
(2005)
Pharmacoeconomics
, vol.23
, Issue.5
, pp. 433-444
-
-
Freeman, E.W.1
-
67
-
-
0036133814
-
Prevalence, incidence and stability of premenstrual dysphoric disorder in the community
-
Wittchen HU, Becker E, Lieb R, Krause P. Prevalence, incidence and stability of premenstrual dysphoric disorder in the community. Psychol. Med. 32, 119-132 (2002).
-
(2002)
Psychol. Med
, vol.32
, pp. 119-132
-
-
Wittchen, H.U.1
Becker, E.2
Lieb, R.3
Krause, P.4
-
68
-
-
3142664613
-
A prospective assessment investigating the relationship between work productivity and impairment with premenstrual syndrome
-
Dean BB, Borenstein JE. A prospective assessment investigating the relationship between work productivity and impairment with premenstrual syndrome. J. Occup. Environ. Med. 46(7), 649-656 (2004).
-
(2004)
J. Occup. Environ. Med
, vol.46
, Issue.7
, pp. 649-656
-
-
Dean, B.B.1
Borenstein, J.E.2
-
69
-
-
12344335514
-
Estimating direct and indirect costs of premenstrual syndrome
-
Borenstein J, Chiou CF, Dean B et al. Estimating direct and indirect costs of premenstrual syndrome. J. Occup. Environ. Med. 47(1), 26-33 (2005).
-
(2005)
J. Occup. Environ. Med
, vol.47
, Issue.1
, pp. 26-33
-
-
Borenstein, J.1
Chiou, C.F.2
Dean, B.3
-
70
-
-
33746172546
-
Evaluating the criteria used for identification of PMS
-
Dean BB, Borenstein JE, Knight K, Yonkers K. Evaluating the criteria used for identification of PMS. J. Womens Health (Larchmt) 15(5), 546-555 (2006).
-
(2006)
J. Womens Health (Larchmt)
, vol.15
, Issue.5
, pp. 546-555
-
-
Dean, B.B.1
Borenstein, J.E.2
Knight, K.3
Yonkers, K.4
-
71
-
-
0036834438
-
Premenstrual dysphoric disorder: Is there an economic burden of illness?
-
Chawla A, Swindle R, Long S et al. Premenstrual dysphoric disorder: is there an economic burden of illness? Med. Care 40(11), 1101-1112 (2002).
-
(2002)
Med. Care
, vol.40
, Issue.11
, pp. 1101-1112
-
-
Chawla, A.1
Swindle, R.2
Long, S.3
-
72
-
-
35348842854
-
Differences in symptom scores and health outcomes in premenstrual syndrome
-
Borenstein JE, Dean BB, Leifke E et al. Differences in symptom scores and health outcomes in premenstrual syndrome. J. Womens Health (Larchmt) 16(8), 1139-1144 (2007).
-
(2007)
J. Womens Health (Larchmt)
, vol.16
, Issue.8
, pp. 1139-1144
-
-
Borenstein, J.E.1
Dean, B.B.2
Leifke, E.3
-
73
-
-
0348038741
-
Health status among women with menstrual symptoms
-
Barnard K, Frayne SM, Skinner KM, Sullivan LM. Health status among women with menstrual symptoms. J. Womens Health (Larchmt) 12(9), 911-919 (2003).
-
(2003)
J. Womens Health (Larchmt)
, vol.12
, Issue.9
, pp. 911-919
-
-
Barnard, K.1
Frayne, S.M.2
Skinner, K.M.3
Sullivan, L.M.4
-
74
-
-
47149098016
-
Premenstrual dysphoric disorder: Burden of illness and treatment update
-
Pearlstein T, Steiner M. Premenstrual dysphoric disorder: burden of illness and treatment update. J. Psychiatry Neurosci. 33(4), 291-301 (2008).
-
(2008)
J. Psychiatry Neurosci
, vol.33
, Issue.4
, pp. 291-301
-
-
Pearlstein, T.1
Steiner, M.2
-
75
-
-
0003433982
-
-
Murray CJL, Lopez AD Eds, Harvard University Press, MA, USA
-
The Global Burden of Disease. Murray CJL, Lopez AD (Eds). Harvard University Press, MA, USA (1966).
-
(1966)
The Global Burden of Disease
-
-
-
76
-
-
38849184642
-
Burden of premenstrual dysphoric disorder on health-related quality of life
-
Yang M, Wallenstein G, Hagan M et al. Burden of premenstrual dysphoric disorder on health-related quality of life. J. Womens Health (Larchmt) 17(1), 113-121 (2008).
-
(2008)
J. Womens Health (Larchmt)
, vol.17
, Issue.1
, pp. 113-121
-
-
Yang, M.1
Wallenstein, G.2
Hagan, M.3
|